The incidence and risk factors of HK and its inter-relationship with WRF , as well as associations with clinical outcome ( death or admission for HF i.e. the primary outcome ) in 3846 HF patients enrolled in the double blind HEAAL trial ( losartan 150 mg/d vs. 50 mg/d ) were assessed .